EUVIMEDEUVIMED entdecken
Crossref

Anticancer agent 6-MITC at extremely low dosage can control seizures by stabilizing membrane excitability system in mutant EL mice

Yoshiya L. Murashima, Shoko Shinoda, Yoko Fuke

Epilepsy & Seizure · 2018

DOI: 10.3805/eands.10.44 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Epilepsy & Seizure, 2018. Verfasst von Yoshiya L. Murashima und 2 weiteren Autor:innen. Die Arbeit nennt 20 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Murashima, Y. L., Shinoda, S., & Fuke, Y. (2018). Anticancer agent 6-MITC at extremely low dosage can control seizures by stabilizing membrane excitability system in mutant EL mice. Epilepsy & Seizure. https://doi.org/10.3805/eands.10.44

Vancouver

Murashima YL, Shinoda S, Fuke Y. Anticancer agent 6-MITC at extremely low dosage can control seizures by stabilizing membrane excitability system in mutant EL mice. Epilepsy & Seizure. 2018. doi:10.3805/eands.10.44

BibTeX
@article{Murashima2018,
  author = {Murashima, Yoshiya L. and Shinoda, Shoko and Fuke, Yoko},
  title = {Anticancer agent 6-MITC at extremely low dosage can control seizures by stabilizing membrane excitability system in mutant EL mice},
  journal = {Epilepsy & Seizure},
  year = {2018},
  doi = {10.3805/eands.10.44}
}
Kostenlos starten →